Gilead Sciences, Inc. (GILD)

Loading financial statements...

Financial statements

data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

Loading holders...

Held by

holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

Holder	Type	ETF	MF	Position ($)	% of holder	Δ % of holder	Holder AUM

Recent insider activity

Last 90 days. Open-market trades (purchases & sales) by directors, officers, and 10%+ owners. 1 transaction across 1 insider. Net: -10,000 shares, -$1,291,608.

Date	Insider	Role	Action	Shares	Price	Value
2026-04-28	O'Day Daniel Patrick	Chairman & CEO	Sell	-10,000 ×2	$129.16	-$1,291,608

Source: SEC Form 4 filings.

Next expected filings

~2026-05-06 10-Q expected by 2026-05-08 (in 5 days)
~2026-08-06 10-Q expected by 2026-08-08 (in 97 days)
~2026-11-06 10-Q expected by 2026-11-08 (in 189 days)
~2027-02-23 10-K expected by 2027-03-01 (in 298 days)

Predicted from historical filing cadence; not an SEC commitment.

Recent SEC filings

2026-04-28 8-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
2026-02-24 10-K Annual Report
2026-02-23 8-K Material Agreement Entered; Regulation FD Disclosure; Financial Statements and Exhibits
2026-02-10 8-K Earnings Release; Financial Statements and Exhibits
2025-11-19 8-K Officer/Director Change
2025-11-07 10-Q Quarterly Report
2025-10-30 8-K Earnings Release; Financial Statements and Exhibits
2025-08-14 8-K Officer/Director Change
2025-08-07 10-Q Quarterly Report
2025-08-07 8-K Earnings Release; Financial Statements and Exhibits
2025-05-07 10-Q Quarterly Report
2025-04-24 8-K Earnings Release; Financial Statements and Exhibits
2025-03-12 8-K Officer/Director Change
2025-02-28 10-K Annual Report
2025-02-11 8-K Earnings Release; Financial Statements and Exhibits

Line item